Detection of Gastric Cancer with Novel Methylated DNA Markers: Discovery, Tissue Validation, and Pilot Testing in Plasma

OBJECTIVE: Gastric adenocarcinoma (GAC) is the third most common cause of cancer mortality worldwide. Accurate and affordable non-invasive detection methods have potential value for screening and surveillance. Herein, we identify novel methylated DNA markers (MDMs) for GAC, validate their discrimina...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Clin Cancer Res
Main Authors: Anderson, Bradley W., Suh, Yun-Suhk, Choi, Boram, Lee, Hyuk-Joon, Yab, Tracy C., Taylor, William R., Dukek, Brian A., Berger, Calise K., Cao, Xiaoming, Foote, Patrick H., Devens, Mary E., Boardman, Lisa A., Kisiel, John B., Mahoney, Douglas W., Slettedahl, Seth W., Allawi, Hatim T., Lidgard, Graham P., Smyrk, Thomas C., Yang, Han-Kwang, Ahlquist, David A.
Formato: Artigo
Idioma:Inglês
Publicado: 2018
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6239895/
https://ncbi.nlm.nih.gov/pubmed/29844130
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-17-3364
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares